Silence’s AtuPLEX technology will be central to research efforts. Silence Therapeutics and AstraZeneca are partnering to develop a range of approaches for the delivery of siRNA molecules. The deal ...
Ribonucleic acid (RNA) interference is a relatively new technique in which small molecules called short interfering RNA (siRNA) can be inserted into cells to turn off a chosen gene. The potential uses ...
China-based companies, others with facilities or collaborative ventures in China, and academic groups all committed to advancing RNA-interference (RNAi) research and therapeutic drug development were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback